Journal of neuroimmunology · 2025
Fisetin alleviates Aβ-induced neuronal cell ferroptosis by regulating Sirt6-mediated deacetylation modification.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Yuqin, Li Changlan, Zhang Yangbo, Liu Xu, Wang Wei, Zheng Lili, Gu Xunhu
Аннотация
BACKGROUND: Ferroptosis contributes to Alzheimer's disease (AD) pathology. Fisetin, a flavonoid with neuroprotective properties, has shown potential in reducing oxidative stress and inflammation. This study investigates the protective effects and underlying molecular pathways of fisetin against amyloid-β (Aβ)-induced ferroptosis in neuronal cells.
METHODS: HT22 mouse hippocampal neuronal cells were pre-incubated with fisetin before exposure to amyloid-β (Aβ). Cell viability was evaluated by Cell Counting Kit-8 (CCK-8) assay, and lipid peroxidation was measured with the C11-BODIPY probe. Protein expression patterns were determined via Western blot analysis. Co-immunoprecipitation (CoIP) and ubiquitination assays were used to explore the interactions between Sirtuin 6 (Sirt6), nuclear factor erythroid 2-related factor 2 (Nrf2), and kelch-like ECH-associated protein 1 (Keap1).
RESULTS: Fisetin pre-treatment significantly alleviated Aβ-induced ferroptosis in HT22 cells. Sirt6 upregulation was observed following fisetin treatment, and silencing Sirt6 reversed its protective effects on Aβ-induced neuronal cell ferroptosis. Mechanistically, Sirt6 deacetylated Nrf2 and enhanced its stability by preventing its degradation through Keap1-mediated ubiquitination. As expected, fisetin alleviated Aβ-induced ferroptosis in neuronal cells through activation of the Sirt6/Nrf2 axis.
CONCLUSION: Fisetin alleviated Aβ-induced neuronal cell ferroptosis by activating the Sirt6/Nrf2 axis. These results underscore fisetin's therapeutic potential for AD by targeting ferroptosis, providing a new strategy for disease intervention.
METHODS: HT22 mouse hippocampal neuronal cells were pre-incubated with fisetin before exposure to amyloid-β (Aβ). Cell viability was evaluated by Cell Counting Kit-8 (CCK-8) assay, and lipid peroxidation was measured with the C11-BODIPY probe. Protein expression patterns were determined via Western blot analysis. Co-immunoprecipitation (CoIP) and ubiquitination assays were used to explore the interactions between Sirtuin 6 (Sirt6), nuclear factor erythroid 2-related factor 2 (Nrf2), and kelch-like ECH-associated protein 1 (Keap1).
RESULTS: Fisetin pre-treatment significantly alleviated Aβ-induced ferroptosis in HT22 cells. Sirt6 upregulation was observed following fisetin treatment, and silencing Sirt6 reversed its protective effects on Aβ-induced neuronal cell ferroptosis. Mechanistically, Sirt6 deacetylated Nrf2 and enhanced its stability by preventing its degradation through Keap1-mediated ubiquitination. As expected, fisetin alleviated Aβ-induced ferroptosis in neuronal cells through activation of the Sirt6/Nrf2 axis.
CONCLUSION: Fisetin alleviated Aβ-induced neuronal cell ferroptosis by activating the Sirt6/Nrf2 axis. These results underscore fisetin's therapeutic potential for AD by targeting ferroptosis, providing a new strategy for disease intervention.